ERYTECH Provides Business and Financial Highlights for First Quarter 2016 Post author:admERY Post published:May 10, 2016 Post category:Newsroom Erytech today provided a business update and reported financial results for its first quarter ended March 31, 2016. You Might Also Like ERYTECH Pharma’s sickle cell treatment receives positive opinion for Orphan Drug Designation from the European Medicines Agency June 13, 2012 ERYTECH engages in collaborative partnership with EU Horizon 2020 EVIDENCE consortium May 5, 2020 ERYTECH to Present at Cowen & Company 39th Annual Healthcare Conference Meeting March 8, 2019
ERYTECH Pharma’s sickle cell treatment receives positive opinion for Orphan Drug Designation from the European Medicines Agency June 13, 2012
